0001562180-23-000045.txt : 20230103
0001562180-23-000045.hdr.sgml : 20230103
20230103164432
ACCESSION NUMBER: 0001562180-23-000045
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221230
FILED AS OF DATE: 20230103
DATE AS OF CHANGE: 20230103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Semigran Marc
CENTRAL INDEX KEY: 0001691494
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40236
FILM NUMBER: 23502794
MAIL ADDRESS:
STREET 1: C/O MYOKARDIA, INC.
STREET 2: 333 ALLERTON AVE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Edgewise Therapeutics, Inc.
CENTRAL INDEX KEY: 0001710072
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 821725586
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3415 COLORADO AVE.
CITY: BOULDER
STATE: CO
ZIP: 80303
BUSINESS PHONE: 303-735-8373
MAIL ADDRESS:
STREET 1: 3415 COLORADO AVE.
CITY: BOULDER
STATE: CO
ZIP: 80303
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2022-12-30
false
0001710072
Edgewise Therapeutics, Inc.
EWTX
0001691494
Semigran Marc
3415 COLORADO AVE
BOULDER
CO
80303
false
true
false
false
Chief Development Officer
Stock Option (Right to Buy)
8.94
2022-12-30
4
A
false
300000.00
0.00
A
2032-12-30
Common Stock
300000.00
300000.00
D
1/4th of the shares subject to the option become vested and exercisable on December 19, 2023 and 1/48th of the shares subject to the option continue to vest each month, subject to the Reporting Person continuing as a service provider through each vest date.
/s/ John R. Moore, Attorney-in-Fact for Semigran Marc
2023-01-03